Paul Swiecicki

University of Michigan

United States

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Collaborators (4)

Keith Casper

UNITED STATES

Daniel Hertz

University of Michigan

UNITED STATES

Andrew Rosko

University of Michigan

UNITED STATES

N Lynn Henry

University of Michigan

UNITED STATES

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Paul Swiecicki

Research Interests

Explore related searches

Contact this professor

Articles (11)

Collaborators (4)

Keith Casper

Daniel Hertz

Andrew Rosko

N Lynn Henry

Make your next move.

Paul Swiecicki

Research Interests

Explore related searches

Contact this professor

Articles (11)

Doublet Therapy: Two Narrative Accounts of One Life-Changing Decision

Tumor immune microenvironment alterations using induction cetuximab in a phase II trial of deintensified therapy for p16-positive oropharynx cancer

Confirmatory DPYD Testing in Patients Receiving Fluoropyrimidines who are Suspected DPYD Variant Carriers Based on a Genetic Data Repository

Randomized Phase II Study of Physiologic MRI-Directed Adaptive Radiation Boost in Poor Prognosis Head and Neck Cancer

Randomized trial of laryngeal organ preservation evaluating two cycles of induction chemotherapy with platinum, docetaxel, and a novel Bcl‐xL inhibitor

Patient and Provider Perspectives on Enrollment in Precision Oncology Research: Qualitative Ethical Analysis

Surveillance and Monitoring Techniques for HPV-Related Head and Neck Squamous Cell Carcinoma: Circulating Tumor DNA

Prediction of Disease Free Survival in Laryngeal and Hypopharyngeal Cancers Using CT Perfusion and Radiomic Features: A Pilot Study

Efficacy of axitinib in metastatic head and neck cancer with novel radiographic response criteria

Impact of extrinsic tongue muscle invasion on stage migration in AJCC 8th edition staging of oral cavity carcinoma

A multi-center phase II trial evaluating the efficacy of palbociclib in combination with carboplatin for the treatment of unresectable recurrent or metastatic head and neck squamous cell carcinoma

Collaborators (4)

Keith Casper

Daniel Hertz

Andrew Rosko

N Lynn Henry

Make your next move.